[The MEN consortium of Japan].
Multiple endocrine neoplasia (MEN) is not as well recognized in Asia, including Japan, as in the West. The clinical features of MEN and management conditions have yet to be clarified in Japan. Thus, we established a MEN study group designated the MEN Consortium of Japan in 2008. Its missions are to: 1) clarify the current status of clinical management of MEN; 2) promote basic research; 3) improve the diagnosis and treatment of MEN; 4) undertake public relations to increase awareness of MEN; and 5) support and collaborate with patient advocacy groups, etc. Clinical and genetic information on more than 1,000 patients was collected and analyzed. The database established by the MEN Consortium of Japan is the first such database for Asian patients and is one of the most extensive MEN databases worldwide. This is anticipated to promote clarification of the current status of MEN in Japan and improve future clinical management.